RashEndZ, Inc. is partnering with the University of South Florida/USF Research, local hospitals, and local long term care facilities to conduct clinical validation testing of the RashEndZ technology and Dynamic Oxygen Skin Therapy. These studies are configured as phase 0 pilot tests to demonstrate comparative efficacy to current treatment protocols. Neonatal patients in multiple NICUs are one group in the study, along with babies in special care nurseries. Adult patients in hospitals are another group planned in this study, along with adult patients in local Long Term Care Facilities.
These studies will be expanded over time to include a number of other candidate diagnoses and wound care applications. Results will be widely distributed through our online community and network of clinical advocate partners.
Testing Schedule: 4th Quarter, 2014.
Join our community
Track our progress
Schedule a demo meeting